PREPARED BY THE CENTER FOR MEDICARE ADVOCACY, INC.

Size: px
Start display at page:

Download "PREPARED BY THE CENTER FOR MEDICARE ADVOCACY, INC."

Transcription

1 MEDICARE DRUG CARDS PROVE INCONSISTENT AND PROVIDE FEW DISCOUNTS FOR MEDICARE BENEFICIARIES TRYING TO REDUCE THE COST OF THE TEN MOST POPULAR BRAND-NAME DRUGS USED BY SENIORS PREPARED BY THE CENTER FOR MEDICARE ADVOCACY, INC.

2 SUMMARY The Medicare Prescription Drug Improvement, and Modernization Act of 2003 [Public Law (Medicare Act)] created the Medicare prescription drug discount card program as a stop-gap measure to assist Medicare beneficiaries with their prescription drug costs from June 2004 through December 31, 2005, until the new Medicare drug benefit takes effect in According to the Centers for Medicare and Medicaid Services (CMS), these drug cards will provide elders and people with disabilities across the United States with significant discounts on prescription drugs. However, since its inception, the Medicare drug card program has been fraught with problems: pharmacies have been listed on the website as participating members of drug card plans when, in fact, they are not; people with Medicare have found the website confusing and additional CMS support unhelpful; drug prices posted on the Medicare.gov website proved to be inaccurate; and the cards have failed to reduce the cost of prescription drugs. 1 Today, the Center for Medicare Advocacy (the Center) is releasing a report regarding other deficiencies with the Medicare drug cards. This report analyzes the price savings that the Medicare drug cards offer seniors in Washington, D.C. (zip code 20009); Willimantic, Connecticut (zip code 06226); and Olney, Maryland (zip code 20832) for the ten most popular brand-name drugs used by seniors. 2 These drugs were included in the Pennsylvania Department of Aging, PACE Program, 2003 High Cost and High Volume Claims (February 2004) report and have been analyzed in studies prepared for CMS and Representative Benjamin L. Cardin (D-MD 3 rd ). FINDINGS 1 Letter to Tommy G. Thompson, Secretary of Health and Human Services, from Henry A. Waxman, Ranking Minority Member for Committee on Government Reform, and Louise McIntosh Slaughter, D-NY 28 th (July 6, 2004). 2 The dosage and quantity of each drug used were: Aricept, 10 mg, 30 tab; Celebrex, 200 mg, 30 cap; Fosamax, 70 mg, 4 tab; Lipitor, 10 mg, 30 tab; Nexium, 40 mg, 30 cpdr; Norvasc, 5 mg, 30 tab; Plavix, 75 mg, 30 tab; Prevacid, 30 mg, 30 cpdr; Zocor, 40 mg, 30 tab; Protonix, 40 mg, 30 tbec.

3 The report finds that the drug cards fail to provide Medicare beneficiaries with significant discounts on prescription drugs. Analysis shows that the Medicare drug cards are both confusing and inconsistent. Specifically, the report finds:! Discounts on prescription drugs vary by zip code and pharmacy. While a study conducted in Maryland s 3 rd Congressional District for Representative Benjamin L. Cardin finds that the prices available with the Medicare drug cards are considerably more expensive than the prices available from Drugstore.com, 3 a price comparison in Washington, D.C. (zip code 20009) using the same drugs finds that the Medicare drug cards do offer modest discounts on some prescription drugs in that zip code. A comparison of drug prices between Medicare.gov (using the Washington, D.C. zip code 20009) and Drugstore.com on July 26, 2004 found that the lowest-priced Medicare drug card offered on the Medicare.gov website provided lower prices for Norvasc, Prevacid, Nexium, Zocor, Protonix, Fosamax, Plavix, and Celebrex, compared to Drugstore.com.! Discounts vary by prescription. Even where the Center found that the Medicare drug discount cards offered better prices, the amount of the discount varied substantially. Please see Appendix A.! The cards fail to provide significant discounts on all prescription drugs. A comparison of drug prices between Medicare.gov (using the Washington, D.C. zip code 20009) and Drugstore.com on July 26, 2004 revealed that some drugs may even be more expensive when purchased with a Medicare drug card than when purchased at Drugstore.com. 3 House Committee on Government Reform, Medicare Drug Cards Provide Few Discounts in Maryland s 3 rd Congressional District (July 2004).

4 Table 1: Drug Prices Using Medicare Drug Cards Which Provide Greatest Discounts Compared to Drug Prices Using Drugstore.com Washington, D.C.; Willimantic, CT; Olney, MD Drug Prices (30 day supply) Lowest-Priced Medicare Drug Card Offered by Medicare.gov Drugstore.com % Discount Aricept $ $ % Lipitor $64.62 $ % Moreover, the price of a month s supply of Plavix at CVS Pharmacy in Washington, DC (zip code 20009) remained constant over ten weeks, stagnating at $ A month s supply of the same drug in Willimantic, Connecticut (zip code 06226) also remained unchanged from May 27, 2004 through July 19, 2004, costing $ In Olney, Maryland, the price of a month s supply of Plavix remained fairly constant using the U Share Prescription Drug Discount Card from May 27, 2004 through July 19, 2004, decreasing by only three cents from $ to $ in two months. Similarly, the price of a month s supply of Aricept remained unchanged from May 26, 2004 through July 19, 2004 at $ at CVS Pharmacy in Washington DC (zip code 20009) using the Public Sector Partners Prescription Drug Discount Card. 4 While CMS claims that the new drug discount cards have lowered the price of prescription medication by between 11 and 18 percent, our research finds such assertions misleading. As others have indicated, prices are in many cases no lower, and in some cases higher, than they were before the law passed. 5 Price comparisons reveal that the cost of drugs purchased with Medicare 4 Data collected by the Center for Medicare Advocacy show that the Medicare drug cards fail to reduce the cost of prescription drugs. Tracking the price of Plavix (75 mg, 30 tab) from May 7, 2004 through July 12, 2004, the Center records that the price of Plavix remained unchanged even after the Medicare drug cards went into effect on June 1, Similar findings exist for other drugs, including Aricept (10 mg, 30 tab). 5 AARP, 6/30/04.

5 drug cards remains higher than that of drugs purchased in Canada or through the Department of Veterans Affairs. 6! Medicare beneficiaries are locked into their discount card choice and can only switch drug card providers in November They are placed at the mercy of drug card providers to consistently offer the same medications on their plan. While some of the Medicare drug discount cards the Center looked at consistently offered the same medications, others suspended service for a week or more. For example, Prescription Discount Card, available June 18, 2004, was listed as unavailable on June 21, 2004 in Washington, D.C. (zip code 20009). Beneficiaries who subscribe to cards which present similar deficiencies may encounter difficulties in obtaining their medication through the Medicare drug discount card plan. METHODOLOGY The Center for Medicare Advocacy analyzed prices for the ten most popular brand-name drugs used by seniors to determine potential problems with the drug card initiative. 7 After identifying the cards which offered the greatest discount on medication for each zip code in the first week of data collection (May 7, 2004), the Center continued to monitor the drug prices for each of the selected cards to determine whether or not the cards provided significant discounts to beneficiaries once they took effect on June 1, The Center examined the price of drugs for only two cards because Medicare beneficiaries are locked into their choice of drug card and are prohibited from switching cards once they have enrolled in a drug card plan. Tracking the price of drugs over ten weeks, the Center looked to determine whether prices remained constant or decreased, as pharmaceutical companies claim. CONCLUSIONS 6 Families USA. Sticker Shock: Rising Prescription Drug Prices for Seniors. (June 2004). 7 The Center for Medicare Advocacy collected data on the ten most popular brand-name drugs used by seniors the same list of drugs examined by Representative Benjamin L. Cardin in Maryland s 3 rd Congressional District.

6 The Center s findings suggest that the Medicare drug cards are not an effective way to lower the cost of prescription drugs. Not only have the cards failed to reduce costs for all beneficiaries, they are confusing and often inconsistent. Data suggest that beneficiaries may confront weeks when their card temporarily does not offer the drug that their doctor has prescribed. While recent updates to the Medicare.gov website have eased beneficiaries ability to compare prices online, the complexity of choices offered may deter some beneficiaries from enrolling in a drug card plan. Studies have shown that, controlling for educational differences, seniors are more likely than nonelderly consumers to have trouble with comparative information to inform health plan choice. Conservative estimates suggest that 56 percent of the Medicare population has difficulty using comparative information. 8 Better coordination of the Medicare drug card program could increase the number of beneficiaries who enroll in these cards, creating wider access to Medicare drug benefits. If we are to believe that CMS administrator Mark McClellan was sincere when he asserted in his July 19, 2004 report that, the Administration is committed to ensuring that each eligible beneficiary has the opportunity to enroll in the drug card program that best meets his or her needs (emphasis added), 9 the Administration should consider implementing the following recommendations:! Provide for uniformity across the country. At present, the amount that beneficiaries save using a Medicare drug card depends upon where they live and what pharmacy they use. The Medicare drug discount program should offer the same prescription drug benefits to beneficiaries no matter where they live or where they shop.! Allow beneficiaries to switch cards, even if they are already enrolled in another Medicare drug discount card plan. CMS administrator, Mark McClellan, claimed in his testimony of July 19, 2004, that, beneficiaries will be using their market clout to drive prices down so that the dollars spent by them and by the government on their behalf will be able to provide more medications than before. 10 Yet the Center s data suggest that under current conditions, only miniscule price differences exist between drug cards 8 Judith H. Hibbard, Paul Slovic, Ellen Peters, Melissa L. Finucane, and Martin Tusler, Is the Informed-Choice Policy Approach Appropriate for Medicare Beneficiaries? Health Affairs (May/June 2001) p Testimony of Mark McClellan, MD, Ph.D., Administrator Centers for Medicare & Medicaid Services, on Medicare Drug Benefit s Impact on Low-Income Beneficiaries Before the Senate Committee on Aging (July 19, 2004) p Ibid, p. 1.

7 (most cards vary in their discounts on drugs by a few dollars). Little competition exists to drive down the price of drugs. Allowing beneficiaries the ability to switch to another card which offers their drug at a lower price would increase competition between Medicare drug discount card providers and lead to lower drug prices overall. While drug card enrollment fees, ranging from zero to 30 dollars, might deter some beneficiaries from taking advantage of this option, differences in some drug prices may prove significant enough for beneficiaries to switch cards.! Decrease the number of cards offered. The large number of cards currently offered has failed to decrease the price of prescription medication through free-market competition. Moreover, the wide range of options currently available is confusing and may deter elderly beneficiaries from enrolling in a drug discount card.! The Center finds that the new Medicare drug discount cards appear to offer inconsistent, if any, benefits to beneficiaries and looks forward to future improvements in efforts to reduce the cost of prescription drugs.

8 APPENDIX A Figure 1: Drug Prices Using Medicare Drug Cards Which Provide Greatest Discounts Compared to Drug Prices Using Drugstore.com Washington, D.C. Drug Prices (30 day supply) Lowest-Priced Medicare Drug Card Offered by Medicare.gov Drugstore.com % Discount Celebrex $74.14 $ % Fosamax $57.18 $ % Nexium $98.90 $ % Norvasc $41.54 $ % Plavix $ $ % Prevacid $ $ % Protonix $68.71 $ % Zocor $97.82 $ %

9 Figure 2: Drug Prices Using Medicare Drug Cards Which Provide Greatest Discounts Compared to Drug Prices Using Drugstore.com Willimantic, CT Drug Prices (30 day supply) Lowest-Priced Medicare Drug Card Offered by Medicare.gov Drugstore.com % Discount Celebrex $74.14 $ % Fosamax $57.18 $ % Nexium $ $ % Norvasc $41.54 $ % Plavix $ $ % Prevacid $ $ % Protonix $68.71 $ % Zocor $97.82 $ %

10 Figure 3: Drug Prices Using Medicare Drug Cards Which Provide Greatest Discounts Compared to Drug Prices Using Drugstore.com Olney, MD Lowest-Priced Drugstore.com % Discount Medicare Drug Card Offered by Medicare.gov Celebrex $74.14 $ % Fosamax $57.18 $ % Nexium $ $ % Norvasc $41.54 $ % Plavix $ $ % Prevacid $ $ % Protonix $68.71 $ % Zocor $97.82 $ % * Please note, however, that not all of the ten drugs surveyed were cheaper using the Medicare drug cards. The prices available with the Medicare drug cards were more expensive than the prices available from Drugstore.com for Lipitor and Aricept in Washington, D.C.; Willimantic, CT; and Olney, MD.

January 16, Dear Administrator Verma:

January 16, Dear Administrator Verma: Ms. Seema Verma Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMMI New Direction P.O. Box 8011 Baltimore, MD 21244-1850 Re: (CMS-4182-P) Medicare

More information

Prescription Drugs. Medicare & Medicaid Briefings National Health Policy Forum February 22, Jim Hahn Congressional Research Service

Prescription Drugs. Medicare & Medicaid Briefings National Health Policy Forum February 22, Jim Hahn Congressional Research Service Prescription Drugs Medicare & Medicaid Briefings National Health Policy Forum February 22, 2007 Jim Hahn Congressional Research Service Global and US. Prescription Drug Sales, 1998-2005 $700 $600 559 602

More information

TRENDS IN MANUFACTURER PRICES OF BRAND-NAME PRESCRIPTION DRUGS USED BY OLDER AMERICANS SECOND QUARTER 2006 UPDATE

TRENDS IN MANUFACTURER PRICES OF BRAND-NAME PRESCRIPTION DRUGS USED BY OLDER AMERICANS SECOND QUARTER 2006 UPDATE TRENDS IN MANUFACTURER PRICES OF BRAND-NAME PRESCRIPTION DRUGS USED BY OLDER AMERICANS SECOND QUARTER 2006 UPDATE INTRODUCTION This Data Digest reports on changes in manufacturer prescription drug prices

More information

Evaluation of a Medicaid Psychotropic Drug Management Program in Utah

Evaluation of a Medicaid Psychotropic Drug Management Program in Utah Evaluation of a Medicaid Psychotropic Drug Management Program in Utah Dominick Esposito James M. Verdier 2008 SAMHSA/CMS Invitational Conference on Medicaid and Mental Health Service/Substance Abuse Treatment

More information

Like others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue.

Like others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue. Statement of Consumers Union William Vaughan, Senior Policy Analyst before the US Food and Drug Administration Public Meeting on Behind the Counter Availability of Drugs November 14, 2007 Consumers Union

More information

Cost-Motivated Treatment Changes in Commercial Claims:

Cost-Motivated Treatment Changes in Commercial Claims: Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non- Medical Switching August 2017 THE MORAN COMPANY 1 Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non-Medical

More information

Safe, effective, affordable drug choices: online tool for payers and patients.

Safe, effective, affordable drug choices: online tool for payers and patients. Executive summary: Rising healthcare costs and greater access to medical information drive patients to seek options for their drug therapy. The MedAlternatives database by Gold Standard/Elsevier empowers

More information

Walgreens (WAG) Analyst: Juan Fabres Fall 2014

Walgreens (WAG) Analyst: Juan Fabres Fall 2014 Recommendation: Buy Target Price August 31, 2016: $77.57 1. Reasons for the Recommendation With the acquisition of Alliance Boots in Europe, Walgreens will be the first US pharmacy to operate retail stores

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on:

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on: Statement Of The National Association of Chain Drug Stores For U.S. Senate Finance Committee Hearing on: 10:30 a.m. 215 Dirksen Senate Office Building National Association of Chain Drug Stores (NACDS)

More information

Pharmacy Costs: Can I Make a Difference?

Pharmacy Costs: Can I Make a Difference? Pharmacy Costs: Can I Make a Difference? Pharmaceutical Market Dynamics What is driving Rx cost up? No New Blockbusters Patent Expirations OTC Market Dynamics Availability Pharmaceutical Companies Unfortunately,

More information

5 $3 billion per disease

5 $3 billion per disease $3 billion per disease Chapter at a glance Our aim is to set a market size large enough to attract serious commercial investment from several pharmaceutical companies that see technological opportunites,

More information

Capitol Insights: A UC Center Sacramento Panel Discussion Soaring Drug Prices: Consumer and Clinician Perspectives and Policy Options

Capitol Insights: A UC Center Sacramento Panel Discussion Soaring Drug Prices: Consumer and Clinician Perspectives and Policy Options Capitol Insights: A UC Center Sacramento Panel Discussion Soaring Drug Prices: Consumer and Clinician Perspectives and Policy Options UCSF Center for Healthcare Value Philip R. Lee Institute for Health

More information

July 30, VIA TO

July 30, VIA  TO July 30, 2012 VIA EMAIL TO DMEPOS@cms.hhs.gov Elliot Klein Centers for Medicare and Medicaid Services 7500 Security Boulevard Mail Stop C5-03-17 Baltimore, MD 21244-1850 RE: Inherent Reasonableness of

More information

How Mail-Servi. Prepared for

How Mail-Servi. Prepared for How Mail-Servi ice Pharmacies Will Save $46.6 Billion Over the Next Decade and the Cost of Proposed Restrictions Prepared for February 2012 Table of Contents I. Executive Summary... 3 Major Findings on

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Committee on Finance. Hearing on:

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Committee on Finance. Hearing on: Statement Of The National Association of Chain Drug Stores For U.S. Senate Committee on Finance Hearing on: 10:00 a.m. National Association of Chain Drug Stores (NACDS) 1776 Wilson Blvd., Suite 200 Arlington,

More information

OFFICE OF THE UNDER SECRETARY OF DEFENSE 4000 DEFENSE PENTAGON WASHINGTON, D.C

OFFICE OF THE UNDER SECRETARY OF DEFENSE 4000 DEFENSE PENTAGON WASHINGTON, D.C OFFICE OF THE UNDER SECRETARY OF DEFENSE 4000 DEFENSE PENTAGON WASHINGTON, D.C. 20301-4000 PERSONNEL AND READINESS The Honorable James M. Inhofe JAN - 7 ;in o Chairman Committee on Armed Services United

More information

Medicare prescription drug coverage: A very long wait for a very modest benefit

Medicare prescription drug coverage: A very long wait for a very modest benefit The American Journal of Medicine (2005) 118, 325-329 EDITORIAL Medicare prescription drug coverage: A very long wait for a very modest benefit James E. Dalen, MD, MPH, Douglas J. Hartz, BS, BPA Arizona

More information

BY-STATE MENTAL HEALTH SERVICES AND EXPENDITURES IN MEDICAID, 1999

BY-STATE MENTAL HEALTH SERVICES AND EXPENDITURES IN MEDICAID, 1999 STATE-BY BY-STATE MENTAL HEALTH SERVICES AND EXPENDITURES IN MEDICAID, 1999 James Verdier,, Ann Cherlow,, and Allison Barrett Mathematica Policy Research, Inc. Jeffrey Buck and Judith Teich Substance Abuse

More information

Re: Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016

Re: Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016 Public Policy Division 202.393.7737 p 1212 New York Ave NW 866.865.0270 f Suite 800 www.alz.org Washington, DC 20005 Andy Slavitt Acting Administrator Centers for Medicare & Medicaid Services Department

More information

Value of Hospice Benefit to Medicaid Programs

Value of Hospice Benefit to Medicaid Programs One Pennsylvania Plaza, 38 th Floor New York, NY 10119 Tel 212-279-7166 Fax 212-629-5657 www.milliman.com Value of Hospice Benefit May 2, 2003 Milliman USA, Inc. New York, NY Kate Fitch, RN, MEd, MA Bruce

More information

Update to HMO Drug Formulary Tier Definitions. February 8, 2018

Update to HMO Drug Formulary Tier Definitions. February 8, 2018 Update to HMO Drug Formulary Tier Definitions February 8, 2018 Agenda 1 Overview of Current Drug Tiers 2 Proposed Drug Tiers for 2019 3 Impact to SFHSS and SFHSS Members 4 How the Drug Formulary Works

More information

In its written comments on our draft report, CMS concurred with our recommendation.

In its written comments on our draft report, CMS concurred with our recommendation. Page 2 Kerry Weems We recommend that Congress and CMS consider the results our review, including the data provided, in any deliberations regarding Medicare Part D reimbursement. In its written comments

More information

LIPITOR AND YOU HELPFUL INFORMATION FOR UNDERSTANDING CHOLESTEROL AND RISKS

LIPITOR AND YOU HELPFUL INFORMATION FOR UNDERSTANDING CHOLESTEROL AND RISKS LIPITOR AND YOU HELPFUL INFORMATION FOR UNDERSTANDING CHOLESTEROL AND RISKS Learn what your cholesterol levels actually mean, and how you may save money on your prescription each month with the LIPITOR

More information

FREE STATEWIDE PRESCRIPTION ASSISTANCE PROGRAM

FREE STATEWIDE PRESCRIPTION ASSISTANCE PROGRAM FREE STATEWIDE PRESCRIPTION ASSISTANCE PROGRAM FLORIDA RX CARD Free statewide prescription assistance program Available to everyone in the state regardless of residency, immigration, or citizenship status

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget.

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget. Statement Of The National Association of Chain Drug Stores For U.S. House of Representatives Committee on the Budget Hearing on: 2:00 p.m. 210 Cannon House Office Building National Association of Chain

More information

JOIN IN AN UNPRECEDENTED STATEWIDE MOVEMENT TO CHANGE HEALTHCARE

JOIN IN AN UNPRECEDENTED STATEWIDE MOVEMENT TO CHANGE HEALTHCARE JOIN IN AN UNPRECEDENTED STATEWIDE MOVEMENT TO CHANGE HEALTHCARE PASBO S STATEWIDE DATA STRATEGY WITH INNOVU PASBO 62 ND ANNUAL CONFERENCE AND EXHIBITS, PITTSBURGH 1 DATA STRATEGY PLATFORM 2 1 WHAT ARE

More information

Re: Docket No. FDA-2009-N-0294 Regulation of Tobacco Products; Request for Comments

Re: Docket No. FDA-2009-N-0294 Regulation of Tobacco Products; Request for Comments VIA Electronic Submission to http://www.regulations.gov September 29, 2009 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Docket

More information

Medicaid Cost Containment and Potential Effects on Diabetic Beneficiaries

Medicaid Cost Containment and Potential Effects on Diabetic Beneficiaries Medicaid Cost Containment and Potential Effects on Diabetic Beneficiaries White Paper October 2003 2003 The Health Strategies Consultancy LLC and Duke University, The Fuqua School of Business For more

More information

Strategies to Prevent Pharmaceutical Waste: Modifying Co-Pay Structures

Strategies to Prevent Pharmaceutical Waste: Modifying Co-Pay Structures Modifying Co-Pay Structures Extended producer responsibility (EPR) is a policy approach in which the producer s responsibility for their product extends to the post-consumer management of that product

More information

Australian Medicinal Cannabis Pricing Analysis

Australian Medicinal Cannabis Pricing Analysis Australian Medicinal Cannabis Pricing Analysis Q3 2018 cannabis access clinics » Entry level product prices fall by close to 50% over 12 months» Number of legal products available up threefold» Pharmacy

More information

Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica

Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica Pharmacy Trends and Management Opportunities Kerry Bendel, R.Ph. Director of Pharmacy Medica September 14, 20 1 Agenda Pharmacy Trend Experience Trend Drivers and Management Opportunities Call to Action

More information

Vaccine Starter Kit Program FAQs

Vaccine Starter Kit Program FAQs Vaccine Starter Kit Program FAQs Program How does this program help Health Mart pharmacies provide vaccines for their customers? McKesson has designed a comprehensive program specifically for Health Mart

More information

REPORT OF THE COUNCIL ON MEDICAL SERVICE

REPORT OF THE COUNCIL ON MEDICAL SERVICE REPORT OF THE COUNCIL ON MEDICAL SERVICE CMS Report -I- Subject: Presented by: Referred to: Hearing Aid Coverage (Resolutions -I- and -I-) Robert E. Hertzka, MD, Chair Reference Committee J (Jeffrey P.

More information

Discount Plan. Conference Information Phone number: Access code Copyright 2009 Careington Corporation :: All Rights Reserved

Discount Plan. Conference Information Phone number: Access code Copyright 2009 Careington Corporation :: All Rights Reserved Choice One Health Care Discount Plan Conference Information Phone number: 916-233-3087 Access code 680-314-113 Noel Ganis Corporate Benefits Marketing Specialist BBSI Agenda Why a health care discount

More information

COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS

COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS Community Oncology Alliance 2 Physician Ratings Consumers want information about quality Have become used to

More information

Prescription drug expenditures are the most rapidly growing component

Prescription drug expenditures are the most rapidly growing component Changing Prescribing Patterns and Increasing Prescription Expenditures in Medicaid Kenneth S. Fink, MD, MGA, MPH 1 Patricia J. Byrns, MD 2 1 Department of Family Medicine, University of North Carolina

More information

Spring Understanding the potential of generic substitution

Spring Understanding the potential of generic substitution Spring 2014 Understanding the potential of generic substitution Understanding the potential of generic substitution Generic pricing reforms and the availability of generics for blockbuster drugs coming

More information

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite

More information

comparisons and helped about 30 patients sign up for First Health Value Plus thinking they would have zero copays on generics. Two days before the dea

comparisons and helped about 30 patients sign up for First Health Value Plus thinking they would have zero copays on generics. Two days before the dea I helped several hundred patients evaluate the best plan for them this year and Coventry s First Health Value Plus was the very best for many of them. I used the Medicare.gov website and put in my pharmacy

More information

December 18, Submitted Electronically

December 18, Submitted Electronically December 18, 2017 Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attn: CMS-4182-P PO Box 8013 Baltimore, MD 21244-8013 Submitted Electronically

More information

PHARMACY COMPLIANCE RISK AREAS FOR 2014

PHARMACY COMPLIANCE RISK AREAS FOR 2014 PHARMACY COMPLIANCE RISK AREAS FOR 2014 2014 San Juan Puerto Rico Regional Compliance Conference Darrell W. Contreras, Esq., LHRM, CHC-F, CHPC, CHRC 5 Risk Areas 1. Overbilling of Herceptin 2. Quality

More information

VIA ELECTRONIC SUBMISSION: September 10, 2018

VIA ELECTRONIC SUBMISSION:   September 10, 2018 VIA ELECTRONIC SUBMISSION: http://www.regulations.gov Seema Verma Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-1691-P 7500 Security Boulevard

More information

Prescription Drug Options for Older Adults: Managing Your Medicines

Prescription Drug Options for Older Adults: Managing Your Medicines Prescription Drug Options for Older Adults: Managing Your Medicines As people age, the likelihood of taking medicines increases; studies show that the more medicines people take, the more likely they are

More information

The 465 medicines in development include: 142 for diabetes, which affects 10.9 million Americans age 65 and older;

The 465 medicines in development include: 142 for diabetes, which affects 10.9 million Americans age 65 and older; Medicines in Development Older Americans The Medicare Population and Leading Chronic Diseases presented by america s biopharmaceutical research companies Overview 2013 REPORT Biopharmaceutical Research

More information

taking at (Jan. 21, 2016) by Older 2016.pdf).

taking at (Jan. 21, 2016) by Older 2016.pdf). HSGAC MINORITY STAFF REPORT MANUFACTURED CRISIS How Devastating Drug Increases Are Harming America s Seniors U.S. Senate Homeland Security & Governmental Affairs Committee, Minority Office Page 1 EXECUTIVE

More information

Getting started with Prime

Getting started with Prime Getting started with Prime How does a pharmacy plan work? When you visit your doctor, he or she may prescribe medicine for you. Here's how the plan works: Take your prescription and member ID card to the

More information

SURVEY ABOUT YOUR PRESCRIPTION CHOICES

SURVEY ABOUT YOUR PRESCRIPTION CHOICES Editor s Note: This online data supplement contains supplemental material that was not included with the published article by William Shrank and colleagues, Patients' Perceptions of Generic Medications,

More information

Cost-Utility Analysis (CUA) Explained

Cost-Utility Analysis (CUA) Explained Pharmaceutical Management Agency Cost-Utility Analysis (CUA) Explained Cost-Utility Analysis (CUA) at PHARMAC Questions and Answers go to page 9 >> This document explains the process that PHARMAC generally

More information

Shanghai. China. Medicine prices, availability and affordability

Shanghai. China. Medicine prices, availability and affordability Shanghai China Medicine prices, availability and affordability Medicine prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing

More information

An Evaluation Of Oregon s Evidence-Based Practitioner- Managed Prescription Drug Plan

An Evaluation Of Oregon s Evidence-Based Practitioner- Managed Prescription Drug Plan Oregon s Drug Plan An Evaluation Of Oregon s Evidence-Based Practitioner- Managed Prescription Drug Plan Oregon s effort to manage drug usage helped curb spending, but health outcomes for patients have

More information

Vaccine Coverage Requirements in the U.S.

Vaccine Coverage Requirements in the U.S. Vaccine Coverage Requirements in the U.S. Richard Hughes IV and Emily Sobel 10.18.17 Avalere Health T 202.207.1300 avalere.com An Inovalon Company F 202.467.4455 1350 Connecticut Ave, NW Washington, DC

More information

MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS

MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS The November 22, 2016 Mid-Year Financial Report referred to changes to drug coverage under the Saskatchewan Drug Plan. What

More information

Department of Legislative Services

Department of Legislative Services Department of Legislative Services Maryland General Assembly 2007 Session SB 105 FISCAL AND POLICY NOTE Revised Senate Bill 105 (The President, et al.) (By Request Administration) Education, Health, and

More information

F OCUS ON H EALTH P OLICY. Disease prevention is of paramount importance for public health in the United States

F OCUS ON H EALTH P OLICY. Disease prevention is of paramount importance for public health in the United States F OCUS ON H EALTH P OLICY Winter 2006 Medicare s Prevention and Drug Benefits Will Work Together to Keep Beneficiaries Healthy Preventive Benefits Go Hand in Hand with Medicare Prescription Drug Benefit

More information

$"% & '( ) " * +, !"##!""$ !*$-!+*" % $&

$% & '( )  * +, !##!$ !*$-!+* % $& ! """# # $"% & '( ')&# '( ) " * +, '( )(*!*$-!+*"!"##!""$ % $& &. / 011 12 ' 32 3 456 3. 3 0 11 32! 71 829:1 1' 3,3 12/ 2 31:181' 337)1 / 111 3 : 39.21)2 231 1 1 13' 223 333 23) 3;3 2 1 1' 11 3 31 333

More information

Testimony of John K. Roman Justice Policy Center Urban Institute

Testimony of John K. Roman Justice Policy Center Urban Institute Testimony of John K. Roman Justice Policy Center Urban Institute Domestic Policy Subcommittee Oversight and Government Reform Committee U.S. House of Representatives Thursday, July 22, 2010 Mr. Chairman

More information

How are Adult Immunizations paid for in the United States?

How are Adult Immunizations paid for in the United States? How are Adult Immunizations paid for in the United States? Litjen (L.J) Tan, MS, PhD Chief Strategy Officer, Immunization Action Coalition Co-Chair, National Adult and Influenza Immunization Summit February

More information

2015 Survey on Prescription Drugs

2015 Survey on Prescription Drugs 2015 Survey on Prescription Drugs AARP Research January 26, 2016 (For media inquiries, contact Gregory Phillips at 202-434-2544 or gphillips@aarp.org) https://doi.org/10.26419/res.00122.001 Objectives

More information

Part D PDE Data and the Opioid Epidemic

Part D PDE Data and the Opioid Epidemic Part D PDE Data and the Opioid Epidemic State Data Resource Center Acumen, LLC August 30, 2017 3:30-4:30pm ET Outline Background Information on Opioid Use Helpful Part D Elements for Analysis How to Perform

More information

RE: CMS-4130-P (Medicare Program; Policy and Technical Changes to the Medicare Prescription Drug Benefit)

RE: CMS-4130-P (Medicare Program; Policy and Technical Changes to the Medicare Prescription Drug Benefit) Herb Kuhn, Acting Deputy Administrator Centers for Medicare & Medicaid Services Hubert H. Humphrey Building 200 Independence Avenue, S.W. Department of Health and Human Services Washington, D.C. 20201

More information

THE POWER OF. Savings through the largest dentist network. Hometown expertise. Measurably superior service

THE POWER OF. Savings through the largest dentist network. Hometown expertise. Measurably superior service THE POWER OF Savings through the largest dentist network Delta Dental Premier is the largest network of dentists across the state and country. Delta Dental PPO SM is one of the largest PPO networks across

More information

Maryland Department of Health and Mental Hygiene /Office of Systems, Operations and Pharmacy. Date Prescription will Start Denying at the

Maryland Department of Health and Mental Hygiene /Office of Systems, Operations and Pharmacy. Date Prescription will Start Denying at the Maryland Medicaid Pharmacy Program & News ViewsNovember 2013 Maryland Department of Health and Mental Hygiene /Office of Systems, Operations and Pharmacy The Antipsychotic Peer Review Program is Expanding!

More information

OCTOBER 2011 MEDICAID AND HIV: A NATIONAL ANALYSIS

OCTOBER 2011 MEDICAID AND HIV: A NATIONAL ANALYSIS OCTOBER 2011 MEDICAID AND HIV: A NATIONAL ANALYSIS MEDICAID AND HIV: A NATIONAL ANALYSIS OCTOBER 2011 Prepared by JEN KATES EXECUTIVE SUMMARY Medicaid, the nation s principal safety-net health insurance

More information

Understanding the Value of Generic Drugs

Understanding the Value of Generic Drugs Understanding the Value of Generic Drugs Generic drugs can help you get the most out of your health care budget. 05.02.306.1 (8/05) Many people believe that when something costs more, it must be of higher

More information

A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP)

A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP) A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP) May 2014 RubiReview Program Overview... 3 Overview... 3 Adherence Packaging (RubiPaks)... 4 Eligibility... 4 Financial

More information

Understanding Your Patient Care Opportunity Report (PCOR)

Understanding Your Patient Care Opportunity Report (PCOR) Understanding Your Patient Care Opportunity Report (PCOR) Use your January/February 208 PCOR to help improve performance on Medicare Part D Clinical Star Ratings measures. Your January/February 208 Patient

More information

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being

More information

Medicare Severity-adjusted Diagnosis Related Groups (MS-DRGs) Coding Adjustment

Medicare Severity-adjusted Diagnosis Related Groups (MS-DRGs) Coding Adjustment American Hospital association December 2012 TrendWatch Are Medicare Patients Getting Sicker? Today, Medicare covers more than 48 million people, and that number is growing rapidly baby boomers are reaching

More information

House Committee on Energy and Commerce House Committee on Energy and Commerce. Washington, DC Washington, DC 20515

House Committee on Energy and Commerce House Committee on Energy and Commerce. Washington, DC Washington, DC 20515 February 28, 2018 The Honorable Michael Burgess, M.D. The Honorable Gene Green Chairman Ranking Member Subcommittee on Health Subcommittee on Health House Committee on Energy and Commerce House Committee

More information

October 3, Dear Representative Hensarling:

October 3, Dear Representative Hensarling: October 3, 2011 The Honorable Jeb Hensarling Co-Chair Joint Select Committee on Deficit Reduction 129 Cannon House Office Building Washington, DC 20515 Dear Representative Hensarling: The undersigned organizations

More information

Jefferies Healthcare Conference. June 2016

Jefferies Healthcare Conference. June 2016 Jefferies Healthcare Conference June 2016 Today s Speakers John Figueroa Chief Executive Officer Vic Breed Chief Financial Officer Joined Genoa in July 2014 Previously served the dual roles of CEO of Apria

More information

Congressional Record December 9, 2009 S12786-S12787

Congressional Record December 9, 2009 S12786-S12787 Congressional Record December 9, 2009 S12786-S12787 Mr. MENENDEZ. I thank the distinguished chairman of the Senate Finance Committee for yielding me the time. Madam President, I rise in strong opposition

More information

Type of intervention Secondary prevention and treatment; Other (medication coverage policy design).

Type of intervention Secondary prevention and treatment; Other (medication coverage policy design). Cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes Rosen A B, Hamel M B, Weinstein M C, Cutler D M, Fendrick A, Vijan S Record Status

More information

Report to Congressional Defense Committees

Report to Congressional Defense Committees Report to Congressional Defense Committees The Department of Defense Comprehensive Autism Care Demonstration Quarterly Report to Congress Second Quarter, Fiscal Year 2017 In Response to: Senate Report

More information

Peer Support Services Improve Clinical Outcomes by Fostering Recovery and Promoting Empowerment

Peer Support Services Improve Clinical Outcomes by Fostering Recovery and Promoting Empowerment Peer Support Services Improve Clinical Outcomes by Fostering Recovery and Promoting Empowerment Optum has recognized the role of peer support services as an integral part of state Medicaid plans and has

More information

OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know

OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know WHAT S NEW UPDATE CUMBERLAND, MD Renata J. Henry, M.Ed. Director, Central East ATTC March 16, 2016 Behavioral Health is Essential to Health

More information

Tobacco Cessation and the Affordable Care Act

Tobacco Cessation and the Affordable Care Act Tobacco Cessation and the Affordable Care Act Jennifer Singleterry Director, National Health Policy American Lung Association Background on ACA 1 Acronyms ACA = Affordable Care Act (healthcare reform)

More information

The Healthy Indiana Plan

The Healthy Indiana Plan The Healthy Indiana Plan House Enrolled Act 1678 A Pragmatic Approach Governor Mitch Daniels July 16, 2007 Indiana s Fiscal Health is Good First Back-to-Back Balanced Budget in Eight Years $1,000.0 Revenue

More information

Re: Impact of Prohibiting HIV Prescription Drug Co-pay Cards from Counting Towards Deductibles and Maximum Out-of-Pocket Expenses

Re: Impact of Prohibiting HIV Prescription Drug Co-pay Cards from Counting Towards Deductibles and Maximum Out-of-Pocket Expenses May 16, 2018 Name Address Re: Impact of Prohibiting HIV Prescription Drug Co-pay Cards from Counting Towards Deductibles and Maximum Out-of-Pocket Expenses Dear : We the 60 undersigned organizations of

More information

Insurance Guide For Dental Healthcare Professionals

Insurance Guide For Dental Healthcare Professionals Insurance Guide For Dental Healthcare Professionals Dental Benefits Basics What is dental insurance? Unlike traditional insurance, dental benefits are not meant to cover all oral healthcare needs. The

More information

The National Mental Health Association

The National Mental Health Association 2001 North Beauregard Street, 12 th Floor, Alexandria, VA 22311 Phone 703-684-7722 TTY 800-433-5959 Fax 703-684-5968 www.nmha.org Cynthia Wainscott, Chair of the Board Michael M. Faenza, President and

More information

Re: Implementation of the Federal Tamper-Resistant Prescription Pad Mandate

Re: Implementation of the Federal Tamper-Resistant Prescription Pad Mandate January 2, 2008 Ms. Carol Herrmann-Steckel Commissioner Alabama Medicaid Agency PO Box 5624 501 Dexter Avenue Montgomery, AL 36103-5624 Re: Implementation of the Federal Tamper-Resistant Prescription Pad

More information

In Australia, brand substitution of

In Australia, brand substitution of Pharmaceutical brand substitution in Australia are there multiple switches per prescription? Abstract Background: In Australia, brand substitution by pharmacists has been possible since 1994. There is

More information

Women s Health Coverage: Stalled Progress

Women s Health Coverage: Stalled Progress FACT SHEET Women s Health Coverage: Stalled Progress SEPTEMBER 2018 New data from the U.S. Census Bureau show that 1 in 10 women lack access to health insurance. This year, progress in reducing the number

More information

Economic Analysis of the NY State Prescription Opioid Tax

Economic Analysis of the NY State Prescription Opioid Tax Department of Economics 807 Union Street Lippman Hall Union College Schenectady NY 12308 518-388-6200 Economic Analysis of the NY State Prescription Opioid Tax Lewis Davis, Ph.D. Professor of Economics

More information

Washington State Medicaid Prescription Drug Purchasing: Preferred Drug List

Washington State Medicaid Prescription Drug Purchasing: Preferred Drug List Washington tate Medicaid Prescription rug Purchasing: Preferred rug List NLPE Conference eptember 21, 2011 John Bowden Joint Legislative udit & eview Committee JLC Background he Joint Legislative udit

More information

PREFACE. Saskatchewan is participating in the Common Drug Review (CDR).

PREFACE. Saskatchewan is participating in the Common Drug Review (CDR). PREFACE OBJECTIVES The Drug Plan has been established to: provide coverage to Saskatchewan residents for quality pharmaceutical products of proven therapeutic effectiveness; reduce the direct cost of prescription

More information

FlexRx 6-Tier. SM Pharmacy Benefit Guide

FlexRx 6-Tier. SM Pharmacy Benefit Guide FlexRx 6-Tier SM Pharmacy Benefit Guide Welcome to FlexRx The AllWays Health Partners FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many

More information

AWARD DESCRIPTION AND APPLICATION PACKAGE

AWARD DESCRIPTION AND APPLICATION PACKAGE AWARD DESCRIPTION AND APPLICATION PACKAGE Award Description Recipient: a graduating student from a Canadian School of Pharmacy Purpose: The purpose of this award is to recognize a graduating student who

More information

Requiring premiums as well as instituting lockout periods and enrollment limits will increase the number of uninsured and result in barriers to care

Requiring premiums as well as instituting lockout periods and enrollment limits will increase the number of uninsured and result in barriers to care July 14, 2017 The Honorable Tom Price, Secretary U.S. Department of Health and Human Services 200 Independence Avenue, SW Washington, DC 20201 Dear Secretary Price, We appreciate the opportunity to comment

More information

Sample Calling Script

Sample Calling Script Sample Calling Script *Please see last page for instructions on sorting your alpha roster to view those members who have yet to renew. Greetings: Be sure to introduce yourself with your title and the constituent/component

More information

Department of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD February 2000 (FDA)

Department of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD February 2000 (FDA) Department of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD 20857 February 2000 (FDA) 00-3237 Be More Careful With Medicines The Food and Drug Administration,

More information

The BIPA Disease Management Demo Project: Improving Outcomes For Medicare Beneficiaries. Prepared for: Disease Management Colloquium June 29, 2004

The BIPA Disease Management Demo Project: Improving Outcomes For Medicare Beneficiaries. Prepared for: Disease Management Colloquium June 29, 2004 The BIPA Disease Management Demo Project: Improving Outcomes For Medicare Beneficiaries Prepared for: Disease Management Colloquium June 29, 2004 General Overview Started in late 90 s as Diabetex, a diabetes

More information

NEW YORK STATE MEDICAID PROGRAM CHIROPRACTOR MANUAL

NEW YORK STATE MEDICAID PROGRAM CHIROPRACTOR MANUAL NEW YORK STATE MEDICAID PROGRAM CHIROPRACTOR MANUAL POLICY GUIDELINES Table of Contents SECTION I - REQUIREMENTS FOR PARTICIPATION IN MEDICAID...2 WHO MAY PROVIDE CARE...2 LIMITED CHIROPRACTIC SERVICE

More information

INSIGHT on the Issues

INSIGHT on the Issues INSIGHT on the Issues AARP Public Policy Institute Rx Watchdog Report: Drug Prices Continue to Climb Despite Lack of Growth in General Inflation Rate AARP s Public Policy Institute finds that average manufacturer

More information

Oxycodone assistance program

Oxycodone assistance program P ford residence southampton, ny Oxycodone assistance program This card cannot be used if prescriptions are covered by: (i) any federal or state healthcare program, including a state medical or pharmaceutical

More information

Annotated Bibliography:

Annotated Bibliography: Annotated Bibliography: Montana Code Annotated 2009. Montana Legislative Services. September 10, 2010 http://data.opi.mt.gov/bills/mca/20/5/20-5-403.htm. A school may not allow a student to attend unless

More information

DECISION AND ORDER. After due notice, a telephone hearing was held on. , Medical Director, also testified as a witness for the MHP.

DECISION AND ORDER. After due notice, a telephone hearing was held on. , Medical Director, also testified as a witness for the MHP. STATE OF MICHIGAN MICHIGAN ADMINISTRATIVE HEARING SYSTEM FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES P.O. Box 30763, Lansing, MI 48909 (517) 373-0722; Fax: (517) 373-4147 IN THE MATTER OF:, MAHS Docket

More information